Cargando…
Eftrenonacog Alfa: A Review in Haemophilia B
Eftrenonacog alfa (Alprolix(®)) is an extended half-life recombinant factor IX (rFIX)-Fc fusion protein (hereafter referred to as rFIXFc). Administered as an intravenous bolus, it is approved for prophylactic use and the treatment of bleeding in patients with haemophilia B in various countries world...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247827/ https://www.ncbi.nlm.nih.gov/pubmed/37081241 http://dx.doi.org/10.1007/s40265-023-01868-7 |